Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|5|657-664

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.5, 2018-03, pp. : 657-664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: macrophage activation markers predict prognosis and decompensation in patients with cirrhosis—linking gut permeability, inflammation and cirrhosis progression

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 851-853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 2, 2018-02 ,pp. : 484-491

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble CD163

By Møller Holger J.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 1, 2012-02 ,pp. : 1-13

Informa Healthcare

Access to resources Recommend Favorite

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 427-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biological variation of soluble CD163

By MØLLER H. J.   PETERSEN P. HYLTOFT   REJNMARK L.   MOESTRUP S. K.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 63, Iss. 1, 2003-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite